K. Toustrup

发表

Development of a hypoxia gene expression classifier with predictive impact for hypoxic modification of radiotherapy in head and neck cancer.

B. S. Sørensen, C. Wiuf, J. Overgaard, 2011, Cancer research.

Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium

P. Lambin, L. Dubois, A. Harris, 2015, Journal of enzyme inhibition and medicinal chemistry.

Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck.

B. S. Sørensen, C. Wiuf, J. Overgaard, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Therapeutics , Targets , and Chemical Biology Development of a Hypoxia Gene Expression Classifier with Predictive Impact for Hypoxic Modification of Radiotherapy in Head and Neck Cancer

B. S. Sørensen, C. Wiuf, J. Overgaard, 2011 .

In vivo Identification and Specificity assessment of mRNA markers of hypoxia in human and mouse tumors

B. S. Sørensen, S. Jakobsen, J. Overgaard, 2011, BMC Cancer.

FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial.

Steen Jakobsen, Jens Overgaard, Jesper Kallehauge, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Hypoxia and local tumour control in squamous cell carcinoma of the anus – a hypothesis-generating study

B. S. Sørensen, K. Spindler, J. Overgaard, 2022, Acta oncologica.

Hypoxia gene expression signatures as prognostic and predictive markers in head and neck radiotherapy.

B. S. Sørensen, J. Overgaard, J. Alsner, 2012, Seminars in radiation oncology.

Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study

J. Overgaard, J. Eriksen, K. Toustrup, 2015, Acta oncologica.

Waiting times for diagnosis and treatment of head and neck cancer in Denmark in 2010 compared to 1992 and 2002.

C. Grau, J. Overgaard, C. Godballe, 2013, European journal of cancer.

Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients

J. Overgaard, J. Alsner, J. Eriksen, 2017, Clinical and translational radiation oncology.

University of Southern Denmark Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients

B. S. Sørensen, J. Overgaard, J. Alsner, 2017 .

Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitro

Jens Overgaard, Jan Alsner, B. S. Sørensen, 2010, Acta oncologica.

Reduction in waiting time for diagnosis and treatment of head and neck cancer – a fast track study

C. Grau, B. Ulhøi, K. Toustrup, 2011, Acta oncologica.

Validation of a 15-gene hypoxia classifier in head and neck cancer for prospective use in clinical trials

Jens Overgaard, Jan Alsner, B. S. Sørensen, 2016, Acta oncologica.

A prognostic profile of hypoxia-induced genes for localised high-grade soft tissue sarcoma

O. S. Nielsen, B. S. Sørensen, J. Overgaard, 2016, British Journal of Cancer.

Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitro

B. S. Sørensen, J. Overgaard, J. Alsner, 2010, Acta oncologica.